| Literature DB >> 35158572 |
Ioannis Savvas1, Kiriaki Pavlidou1, Tilemachos Anagnostou1, Eugenia Flouraki2, George Kazakos1, Dimitrios Raptopoulos1.
Abstract
In animals, gastro-oesophageal reflux (GOR) may occur during anaesthesia, and it can lead to severe consequences such as oesophagitis and oesophageal stricture. This systematic review investigates the effect of fasting duration and anaesthetic and nonanaesthetic drugs on GOR in dogs and cats during general anaesthesia. Fifteen clinical studies met the inclusion criteria in this systematic review. In thirteen studies the population was dogs, while in two studies the population was cats. In the meta-analysis, seven studies were included. Four studies on the effect of fasting duration on GOR in dogs were included in the meta-analysis. In total, 191 dogs had a fasting duration less than 5 h, while 311 dogs had a fasting duration more than 5 h. The heterogeneity of the studies was high and statistically significant (p = 0.0002, I2 = 85%), but the overall effect was statistically nonsignificant (p = 0.82, odds ratio = 0.81, 95% CI 0.15, 4.26), in favour of the low fasting duration (<5 h). Concerning the effect of antacids on GOR, three studies were included in the meta-analysis. The heterogeneity of the studies was low and nonsignificant (p = 0.13, I2 = 52%) and the overall effect was statistically nonsignificant (p = 0.24). The low number of studies and the diverse factors affecting the incidence of reflux prevented us from reaching valuable conclusions on the risk factors for GOR.Entities:
Keywords: anaesthesia; cat; dog; gastro-oesophageal reflux
Year: 2022 PMID: 35158572 PMCID: PMC8833530 DOI: 10.3390/ani12030247
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1Study flow diagram.
Intervention: duration of fasting. Characteristics of the studies in dogs.
| Reference | Type of Study/Design | Animals (Dogs) | Control/ | Type of Drugs Used | Procedure |
|---|---|---|---|---|---|
| Galatos et al., 1995 [ | prospective cohort clinical study | 240 (125 females, 115 males), age 6 months–9 years, weight 2.5 to 46 kg | 2–4 h/12–18 h | propionylpromazine, atropine, xylazine, pethidine, diazepam, thiopentone, halothane | nonabdominal, nonthoracic |
| Savvas et al., 2016 [ | randomized clinical trial | 120, age 1–8 years, weight 4.6–42 kg | 3 h/10 h | propionyl promazine, thiopentone, halothane | nonabdominal, nonthoracic, no head tilt |
| Viskjer 2017 et al. [ | prospective, randomized, controlled clinical trial | 82, age 48.39 ± 35.31 months, weight 27.37 ± 13.14 kg | 3 h/18 h | acepromazine, methadone, morphine, propofol, isoflurane, morphine epidurally in some dogs | orthopaedic surgery |
| Tsompanidou et al., 2022 [ | prospective, randomized, controlled clinical trial | 90 (37 females, 53 males), age 1–10 years, weight 5–39 kg | 3 h/12 h | acepromazine, pethidine, propofol, isoflurane | nonabdominal, nonthoracic |
Intervention: induction agent. Characteristics of the study in dogs.
| Reference | Type of Study/Design | Animals (Dogs) | Control/Intervention | Fasting | Procedure |
|---|---|---|---|---|---|
| Raptopoulos et al., 1997 [ | randomized clinical trial | 68 (35 females, 33 males), age 6 months–9 years, weight 2.5–50 kg | thiopentone/propofol | 12–18 h | soft tissue, orthopaedic, imaging |
Intervention: inhalant agents. Characteristics of the study in dogs.
| Reference | Type of Study/Design | Animals (Dogs) | Control/Intervention | Fasting Duration | Procedure |
|---|---|---|---|---|---|
| Wilson et al., 2006 [ | randomized, prospective clinical trial | 90 dogs, various ages and weights | halothane/isoflurane or sevoflurane | overnight | orthopaedic surgery |
Intervention: use of opioids. Characteristics of the study in dogs.
| Reference | Type of Study/Design | Animals (Dogs) | Control/Intervention | Fasting | Procedure |
|---|---|---|---|---|---|
| Wilson et al., 2005 [ | randomized, prospective clinical trial | 90, age 4.8 ± 2.4 years, weight 32 ± 2.7 kg | no morphine/morphine at 0.22 mg/kg or 1.10 mg/kg | overnight | orthopaedic surgery |
Intervention: use of antacids. Characteristics of the studies in dogs.
| Reference | Type of Study/Design | Animals (Dogs) | Control/Intervention | Fasting | Procedure |
|---|---|---|---|---|---|
| Panti et al., 2009 [ | randomized, blinded, controlled clinical trial | 47, weight 32.7 ± 14.3 kg | no omeprazole/omeprazole 1 mg/kg | >12 h | pelvic limb surgery |
| Zacuto et al., 2012 [ | prospective, randomized, blinded, placebo-controlled study | 61, age 4.9 ± 3.4 years, weight 25.0 ± 12.9 kg | saline/esomeprazole 1 mg/kg or esomeprazole 1 mg/kg and cisapride 1 mg/kg | >12 h | orthopaedic surgery |
| Lotti et al., 2021 [ | prospective, randomised, blinded, clinical trial | 55, age 5–60 months, weight 21 ± 6.9 kg | no omeprazole/omeprazole 1 mg/kg or omeprazole two doses of 1 mg/kg each | >12 h | ovariectomy |
Intervention: use of metoclopramide. Characteristics of the studies in dogs.
| Reference | Type of Study/Design | Animals (Dogs) | Control/Intervention | Fasting | Procedure |
|---|---|---|---|---|---|
| Wilson et al., 2006 [ | prospective, randomised, clinical trial | 52, ages and weights not mentioned | saline/metoclopramide 0.4 mg/kg or 1.0 mg/kg | overnight | orthopaedic surgery |
| Favarato et al., 2012 [ | randomized, controlled clinical study | 90 (female), age 0.5–9 years, weight 1.5–34 kg | no metoclopramide/metoclopramide 1 mg/kg or ranitidine 2 mg/kg | 12 h | ovariohysterectomy |
Intervention: use of maropitant. Characteristics of the study in dogs.
| Reference | Type of Study/Design | Animals (Dogs) | Control/Intervention | Fasting | Procedure |
|---|---|---|---|---|---|
| Johnson et al., 2014 [ | randomized, blinded, prospective clinical study | 26 (18 females, 8 males), age 3.1 ± 3.1 years, weight 20.5 ± 11.4 kg | saline/maropitant 1.0 mg/kg | >12 h | soft tissue and orthopaedic surgery |
Characteristics of the two studies in cats.
| Reference | Type of Study/Design | Animals (Cats) | Control/Intervention | Fasting | Procedure |
|---|---|---|---|---|---|
| Galatos et al., 2001 [ | randomized, clinical trial | 50 (2 females, 48 males), age 6 months–8 years, weight 2.9–6.3 kg | thiopentone/propofol | overnight | castration, skin tumour excision, orthopaedic surgery |
| Garcia et al., 2017 [ | prospective, blinded, placebo-controlled, randomized clinical trial | 27, age 8.6 ± 3.8 years, weight 5.5 ± 0.8 kg | placebo/two different doses of omeprazole | 12 h | dental procedures |
Figure 2Methodological quality graph: review authors’ judgements about each methodological quality item presented as percentages across all included studies.
Figure 3Methodological quality summary: review authors’ judgements about each methodological quality item for each included study. ?: unclear risk, −: high risk; +: low risk.
Figure 4Forest plot of the effect of fasting time on GOR. CI: confidence interval. ?: unclear risk, −: high risk; +: low risk.
Figure 5Forest plot of the effect of antacids on GOR. CI: confidence interval. ?: unclear risk; +: low risk.